138 research outputs found
Interview with Dr. Ulrich Rodeck, MD, PhD
Dr Dicker interviews Dr Ulrich Rodeck, MD, PhD, Professor, Dermatology & Cutaneous Biology.
Dr Rodeck discusses his roots in Germany and the difference in academic structure in Germany compared to when he came to the USA.
He tells us about his education and research, and some of the things he is now working on.
Presentation: 42:0
Extracellular Matrix Composition Modulates Cell Cycle Checkpoint Control: A New Twist to Radiation Sensitivity
Skin toxicity caused by EGFR antagonists—An autoinflammatory condition triggered by deregulated IL‐1 signaling?
Recessive Dystrophic Epidermolysis Bullosa–Associated Squamous-Cell Carcinoma: An Enigmatic Entity with Complex Pathogenesis
Expression of either collagen VII or the noncollagenous (NC1) fragment derived from it has been suggested to be indispensable for the development of squamous-cell carcinomas (SCCs) in patients affected by recessive dystrophic epidermolysis bullosa (RDEB). This view is challenged here by the observation that SCCs do develop in RDEB patients lacking expression of collagen VII altogether. The aggressive behavior of RDEB-associated SCCs remains unexplained
Integration of Investigative Dermatology into the Global Biomedical Research Enterprise: Past, Present, and Future
Clinical dermatology as a specialty of medicine has made major strides over the past several decades, and major advances in both diagnostic and therapeutic management of skin diseases have benefited patients. The progress in clinical dermatology to a large extent has relied on the robust academic infrastructure developed in recent decades, and we argue that this process has been significantly enhanced by technical innovations in molecular medicine and the integration of cutaneous biology research into the global biomedical research enterprise
- …
